top of page
Home
About
Our Team
Board of Directors
Advisors
Pipeline
Science
For Patients
In The News
Contact Us
Back to News
November 28, 2022
Kaerus BIO CEO Robert Ring Chairs Panel on Fragile X and Rett Syndromes at the 2022 Rare CNS & Neurodevelopmental Drug Development Summit
Kaerus Bio CEO Robert Ring will chair a panel on Fragile X syndrome at the 2nd Annual Rare CNS & Neurodevelopmental Drug Development Summit being held in Boston, MA on November 28-30. Dr Ring joins other global experts on Rett and Fragile X in this pre-conference workshop, including FRAXA co-founder and CMO Dr Mike Tranfagila and Anavex CSO Dr Walter Kaufmann, to discuss the recent advances in treatment development for both of these rare genetic syndromes of neurodevelopment.
bottom of page
.png)
